Explore
Validate
LearnAb170514
antibody from Aladdin Scientific
Targeting: FGFR2
BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab170514 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Bemarituzumab (anti-FGFR2)
- Antibody type
- Recombinant
- Description
- Bemarituzumab (anti-FGFR2) is a recombinant monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human, Mouse
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Bemarituzumab (anti-FGFR2) (Ab170514) - ELISA Immobilized hu-FGFR2-β-IIIb-ECD-His 2 μg/mL can bind Bemarituzumab (anti-FGFR2) (Ab170514) with the EC₅₀ of 13.35 ng/mL.
